Cross-Reactive Polyclonal Antibodies to the Inner Core of Lipopolysaccharide from Neisseria meningitidis
Open Access
- 1 March 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (3) , 1293-1300
- https://doi.org/10.1128/iai.70.3.1293-1300.2002
Abstract
Sera from mice immunized with native or detergent-extracted outer membrane vesicles derived from lipopolysaccharide (LPS) mutant 44/76 Mu-4 of Neisseria meningitidis were analyzed for antibodies to LPS. The carbohydrate portion of 44/76 Mu-4 LPS consists of the complete inner core, Glcβ1→4[GlcNAc α1→2Hep α1→3]Hep α1→5KDO[4→2αKDO]. Immunoblot analysis revealed that some sera contained antibodies to wild-type LPS which has a fully extended carbohydrate chain of immunotype L3,7, as well as to the homologous LPS. Sera reacted only weakly to LPS from 44/76 Mu-3 , which lacks the terminal glucose of the inner core. No binding to more truncated LPS was observed. Consequently, the cross-reactive epitopes are expressed mainly by the complete inner core. Dephosphorylation of wild-type LPS abolished antibody binding to LPS in all but one serum. Thus, at least two specificities of cross-reactive antibodies exist: one is dependent on phosphoethanolamine groups in LPS, and one is not. Detection of these cross-reactive antibodies strongly supports the notion that epitopes expressed by meningococcal LPS inner core are also accessible to antibodies when the carbohydrate chain is fully extended. Also, these inner core epitopes are sufficiently immunogenic to induce antibody levels detectable in polyclonal antibody responses. Meningococci can escape being killed by antibodies to LPS that bind only to a specific LPS variant, by altering the carbohydrate chain length. Cross-reactive antibodies may prevent such escape. Therefore, inner core LPS structures may be important antigens in future vaccines against meningococcal disease.Keywords
This publication has 37 references indexed in Scilit:
- Quantification of Lipopolysaccharides in Outer Membrane Vesicle Vaccines Against Meningococcal Disease. High-performance Liquid Chromatographic Determination of the Constituent 3-Hydroxy-lauric AcidBiologicals, 2002
- Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune responseVaccine, 1997
- Heterogeneity of lipopolysaccharides of Neisseria meningitidis revealed by thin-layer chromatography combined with monoclonal antibodiesJournal of Microbiological Methods, 1996
- Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodiesJournal of Medical Microbiology, 1994
- Structure of the L1 and L6 core oligosaccharide epitopes of NeisseriameningitidisCanadian Journal of Chemistry, 1990
- Multilocus Genotypes Determined by Enzyme Electrophoresis of Neisseria meningitidis Isolated from Patients with Systemic Disease and from Healthy CarriersMicrobiology, 1986
- Structural determination of the group K capsular polysaccharide of Neisseriameningitidis: a 2D-NMR analysisCanadian Journal of Chemistry, 1985
- Structural determination of the capsular polysaccharide of Neisseria meningitidis group I: a two-dimensional NMR analysisBiochemistry, 1985
- Structural elucidation of the capsular polysaccharide of Neisseriameningitidis group HCanadian Journal of Chemistry, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970